Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mouhamad Nasser

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Medicine|September 23, 2021
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in FranceVincent Cottin, Sophie Larrieu, Loic Boussel, et al.
Frontiers in Medicine|April 8, 2024
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitisCharlene Desaintjean, Kaïs Ahmad, Julie Traclet, et al.
Respiration; International Review of Thoracic Diseases|December 1, 2020
Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary FibrosisPierre-Henri Aussedat, Nader Chebib, Kais Ahmad, et al.
Respiratory Research|May 25, 2021
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Loic Boussel, et al.
The European Respiratory Journal|September 18, 2020
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Interstitial Lung Diseases AssemblySabina A Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, et al.
Respiratory Research|April 10, 2024
Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition diseaseFrançois Lestelle, Catherine Beigelman, David Rotzinger, et al.
Respiratory Medicine and Research|April 23, 2023
French recommendations for the diagnosis and management of lymphangioleiomyomatosisVincent Cottin, Elodie Blanchard, Mallorie Kerjouan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Medicine|September 23, 2021
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in FranceVincent Cottin, Sophie Larrieu, Loic Boussel, et al.
Frontiers in Medicine|April 8, 2024
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitisCharlene Desaintjean, Kaïs Ahmad, Julie Traclet, et al.
Respiration; International Review of Thoracic Diseases|December 1, 2020
Impact of Lung Biopsy on Lung Function in Idiopathic Pulmonary FibrosisPierre-Henri Aussedat, Nader Chebib, Kais Ahmad, et al.
Respiratory Research|May 25, 2021
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Loic Boussel, et al.
The European Respiratory Journal|September 18, 2020
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, et al.
ERJ Open Research|May 26, 2022
ERS International Congress 2021: highlights from the Interstitial Lung Diseases AssemblySabina A Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, et al.
Respiratory Research|April 10, 2024
Phenotypes and outcome of diffuse pulmonary non-amyloid light chain deposition diseaseFrançois Lestelle, Catherine Beigelman, David Rotzinger, et al.
Respiratory Medicine and Research|April 23, 2023
French recommendations for the diagnosis and management of lymphangioleiomyomatosisVincent Cottin, Elodie Blanchard, Mallorie Kerjouan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Pageof 4